Latest filing published 17 Nov 2021 for Scopus BioPharma Inc..
Insider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +197.4%Entry US$15.50 · Close at T+365 US$46.10
- +211.0%Entry US$16.30 · Close at T+365 US$50.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Paul Hopper: trading record in brief
Filings by Paul Hopper span 2 companies, the busiest being EyePoint, Inc. and Scopus BioPharma Inc. The record holds 6 filings, for trades running from 1 October 2012 to 1 June 2021.
Every open-market trade on record is a purchase: 4 purchases worth €26k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Half of the purchases are above €6,382 and half below. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -17.1%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 17 November 2021: a transaction, in Scopus BioPharma Inc. The most recent open-market purchase was published on 9 October 2012, 5,143 days ago. Filings reach the SEC (Form 4) feed a median of 8 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Paul Hopper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,333 sharesCommon StockSEC:0000895813-21-000017:1
- 700,000 sharesCommon StockSEC:0000895813-21-000017:0
- 5,000 shares@ US$1.68Common StockSEC:0000904454-12-000538:0Canonical exit: 30 Dec 2012 (T+90)
- 5,000 shares@ US$1.67Common StockSEC:0000904454-12-000538:1Canonical exit: 30 Dec 2012 (T+90)
- 5,000 shares@ US$1.62Common StockSEC:0000904454-12-000536:0Canonical exit: 30 Dec 2012 (T+90)
- 5,000 shares@ US$1.61Common StockSEC:0000904454-12-000536:1Canonical exit: 30 Dec 2012 (T+90)
6 of 6 declarations
